ACTA1 and chronic kidney disease: Importantly, MYDGF reduction in the tubules was also confirmed in patients with CKD (Figure 1g), and the level of MYDGF correlated with Vimentin, α‐SMA, and eGFR (Figure 1h‐j), suggesting that tubular MYDGF is involved in kidney fibrosis and dysfunction in CKD.